Walleye Capital’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
VPM
VCM
KBG
PMG
Walleye Capital's OGN Position: Q1 2026 in Review
Walleye Capital reduced its Organon & Co (OGN) stake by 74% in Q1 2026, selling an estimated $8.22M and leaving 393,125 shares worth $2.35M. The position accounts for 0.01% of the portfolio, ranked #1344.
Walleye Capital first reported a position in OGN in Q1 2023 and has held it in 11 quarters since. The position peaked at $10.7M in Q4 2025. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.
- Walleye Capital held 393,125 shares of Organon & Co worth $2.35M as of Q1 2026.
- Walleye Capital sold 1,092,254 Organon & Co shares in Q1 2026, an estimated $8.22M.
- Organon & Co made up 0.01% of Walleye Capital's portfolio in Q1 2026, its #1344 holding.
- Walleye Capital first reported a position in Organon & Co in Q1 2023 and has held it in 11 quarters since.
- Walleye Capital's Organon & Co position peaked at $10.7M in Q4 2025.
- 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.
Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.